Effect of acarbose on glucose intolerance in patients with non-insulin- dependent diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 37, Issue 2, 1997, Pages 129-136

  Noda, Katsumi ^a   Umeda, Fumio ^b   Nawata, Hajime ^b  

^a HARASANSHIN HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Acarbose; Glucose tolerance; Insulin resistance; Non insulin dependent diabetes mellitus; Principal component analysis

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION;

ACARBOSE; ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; EATING; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; MIDDLE AGED; TIME FACTORS; TRISACCHARIDES;

EID: 0030844261     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(97)00066-1     Document Type: Article

References (16)

1. D.D. Schmidt, W. Frommer, B. Junge, L. Muller, W. Wingender, P.E. Truscheit, α-Glucosidase inhibitors: New complex oligosaccharides of microbial origin, Naturwissenschaften 64 (1977) 535-536.
2. W. Puls, U. Keup, H.P. Krause, G. Thomas, F. Hoffmeister, Glucosidase inhibition: A new approach to the treatment of diabetes, obesity and hyperlipoproteinaemia, Naturwissenschaften 64 (1977) 536-537.
3. W.F. Caspary, S. Graf, Inhibition of human intestinal α-glucosidehydrolases by a new complex oligosaccharide, Res. Exp. Med. (Berlin) 175 (1979) 1-6.
4. D. Sailer, G. Roder, Treatment of non-insulin-dependent diabetic adults with a new glycoside hydrolase inhibitor (Bay g 5421), Arzneimittelforschung 30 (1980) 2182-2185.
5. R. Aubell, K. Boehme, P. Berchtold, Blood glucose concentration and glycouria during and after one year of acarbose therapy, Arzneimittelforschung 33 (1983) 1314-1318.
6. R. Aubell, K. Boehme, P. Berchtold, One-year acarbose treatment of diabetic out-patients. Multicenter study part II: Efficacy, in: W. Creutzfeldt (Ed.), Proceedings of the First International Symposium on Acarbose. International Congress Series, Excerpta Medica, Amsterdam, 1982, pp. 363-366.
7. T. Hayakawa, A. Noda, Kondo, N. Okamura, Effects of acarbose, an α-glucosidase inhibitor (Bay g 5421), on orally loaded glucose, maltose and sucrose and on blood glucose control in non-insulin-dependen diabetics, Nagoya J. Med. Sci. 47 (1984) 35-41.
8. H. Vierhapper, A. Bratusch-Marrain, W. Waldhausl, α-Glucoside hydrolase inhibition in diabetes, Lancet ii (1978) 1386-1387.
9. E. Cerasi, S. Efendic, R. Luft, Dose-response relationship of plasma insulin and blood glucose levels during oral glucose loads in prediabetic and diabetic subjects, Lancet i (1973) 794-797.
10. C.N. Hales, The pathogenesis of NIDDM, Diabetologia 37 (Suppl. 2) (1994) S162-S168.
11. J.H. Livesey, S.C. Hodgkinson, H.R. Roud, R.A. Donald, Effect of time, temperature and freezing on the stability of immunoreactive LH, FSH, TSH, growth hormone, prolactin and insulin in plasma, Clin. Biochem. 13 (1980) 151-155.
12. I. Hillebrand, K. Boehme, G. Frank, H. Fink, P. Berchtold, The effects of the α-glycosidase inhibitor BAY g 5421 on meal-stimulated blood glucose, serum insulin and triglyceride levels in man, Res. Exp. Med. 175 (1979) 81-86.
13. F. Schumann, K. Janssen, R. Aubell, H.H. Christi, Acarbose in diabetic out-patients treatment: Results of a 3-month study, in: W. Creutzfeldt (Ed.), Proceedings of the First International Symposium on Acarbose. Interational Congress Series, Excerpta Medica, Amsterdam, 1982, pp. 367-372.
14. J.D. Best, R.G. Judzewitsch, M.A. Pfeifer, J.C. Beard, J.B. Halter, D. Porte Jr, The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes, Diabetes 31 (1982) 333-338.
15. H. Glauber, P. Wallace, G. Brechtel, Effects of fasting on plasma glucose and prolonged tracer measurement of hepatic glucose output in NIDDM, Diabetes 36 (1987) 1187-1194.
16. J.L. Chiasson, R.G. Josse, L.A. Leiter, M. Mihic, D.M. Nathan, C. Palmason, R.M. Cohen, T.M.S. Wolever, The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance, Diabetes Care 19 (1996) 1190-1193.